Sterling Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Sterling Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$107K	Sell	1,425 -288	-17%	-$22.7K	﹤0.01%	1374
2025 Q4	$136K	Buy	1,713 +815	+91%	+$61.4K	﹤0.01%	1424
2025 Q3	$58.7K	Sell	898 -64	-7%	-$3.13K	﹤0.01%	1708
2025 Q2	$38K	Sell	962 -139	-13%	-$4.55K	﹤0.01%	1575
2025 Q1	$33.2K	Sell	1,101 -1,909	-63%	-$62.5K	﹤0.01%	1527
2024 Q4	$105K	Sell	3,010 -35	-1%	-$1.31K	﹤0.01%	1428
2024 Q3	$122K	Buy	+3,045	New	+$142K	﹤0.01%	1364
2015 Q1	–	Sell	-32,703	Closed	-$2.02M	–	914
2014 Q4	$2.02M	Sell	32,703 -29,892	-48%	-$1.48M	0.02%	391
2014 Q3	$2.43M	Sell	62,595 -4,075	-6%	-$144K	0.03%	308
2014 Q2	$2.3M	Sell	66,670 -16,917	-20%	-$533K	0.02%	306
2014 Q1	$3.61M	Sell	83,587 -34,200	-29%	-$1.66M	0.03%	206
2013 Q4	$4.69M	Buy	+117,787	New	+$4.2M	0.04%	172

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sterling Capital Management's IONS Position: Q1 2026 in Review

Sterling Capital Management reduced its Ionis Pharmaceuticals (IONS) stake by 17% in Q1 2026, selling an estimated $22.7K and leaving 1,425 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

Sterling Capital Management first reported a position in IONS in Q4 2013 and has held it in 12 quarters since. The position peaked at $4.69M in Q4 2013. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Sterling Capital Management held 1,425 shares of Ionis Pharmaceuticals worth $107K as of Q1 2026.
Sterling Capital Management sold 288 Ionis Pharmaceuticals shares in Q1 2026, an estimated $22.7K.
Ionis Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #1374 holding.
Sterling Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2013 and has held it in 12 quarters since.
Sterling Capital Management's Ionis Pharmaceuticals position peaked at $4.69M in Q4 2013.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.